0001213900-20-023991.txt : 20200929 0001213900-20-023991.hdr.sgml : 20200929 20200827150941 ACCESSION NUMBER: 0001213900-20-023991 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PAINREFORM LTD. CENTRAL INDEX KEY: 0001801834 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 60C MEDINAT HAYEHUDIM CITY: HERZLIYA STATE: L3 ZIP: 4676670 BUSINESS PHONE: 972-9-960-1901 MAIL ADDRESS: STREET 1: 60C MEDINAT HAYEHUDIM CITY: HERZLIYA STATE: L3 ZIP: 4676670 CORRESP 1 filename1.htm

August 27, 2020

VIA EDGAR

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Re:

PainReform Ltd.

Registration Statement on Form F-1, as amended (File No. 333-239576)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as the underwriter of the proposed offering of PainReform Ltd. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 4:00 p.m., Eastern Time, on Monday, August 31, 2020, or as soon thereafter as is practicable.

Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned advises that as of the date hereof, 334 copies of the Preliminary Prospectuses dated August 5, 2020, August 10, 2020 and August 24, 2020 have been distributed to prospective dealers, institutional investors, retail investors and others.

The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities and Exchange Act of 1934, as amended.

	Very truly yours,

	Maxim Group LLC

	By:	/s/ Clifford A. Teller
		Name: Clifford A. Teller Title: Head of Investment Banking, Executive Managing Director